TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›MAAS›Financials
Annual statements · SEC XBRL · FY2021 – FY2025

Maase Inc. (MAAS) financials

Income statement

Maase Inc. (MAAS) income statement, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$29.6M$28.2M$15.8M$163M$109M
Revenue growth—-4.8%-44.0%933.5%-33.1%
Operating income-$11.3M-$11.1M-$8.11M-$63.4M-$96.5M
Operating margin-38.3%-39.3%-51.4%-38.9%-88.5%
Net income-$7.13M-$9.06M-$6.01M-$39.9M-$27.4M
Net margin-24.1%-32.1%-38.1%-24.4%-25.1%
EPS (diluted)-$0.08-$0.10-$0.07-$0.17-$3.61

Cash flow

Maase Inc. (MAAS) cash flow, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Operating cash flow-$438K-$1.43M-$25.4M$7.95M$9.98M
Capital expenditures$1.31M$708K$121K$593K$774K
Free cash flow-$1.74M-$2.13M-$25.5M$7.35M$9.20M
Share buybacks———$1.38M—

Balance sheet

Maase Inc. (MAAS) balance sheet, annual, from SEC filings
Fiscal yearFY2021FY2022FY2023FY2024FY2025
Cash & equivalents$40.4M$29.0M$164M$40.7M$11.5M
Total assets$72.5M$69.3M$37.4M$589M$470M
Total liabilities$22.9M$30.4M$7.52M$225M$164M
Shareholders' equity$49.6M$38.8M$29.9M$177M$88.8M
Retained earnings$11.3M$1.77M-$4.34M-$44.2M-$72.2M
Shares (wtd avg diluted)90.5M90.5M1.01M2.59M7.61M

Every figure is extracted from Maase Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Maase Inc.'s annual revenue?
Maase Inc. (MAAS) reported $109M of revenue for fiscal year 2025 — down 33.1% from $163M in FY2024, per its annual report filed with the SEC.
Is Maase Inc. profitable?
Not in FY2025 — MAAS reported a net loss of $27.4M, per SEC filings.
What is Maase Inc.'s free cash flow?
$9.20M in FY2025 (operating cash flow $9.98M minus $774K of capital expenditures), from the SEC cash-flow statement.
Does MAAS pay a dividend?
Maase Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full MAAS analysis — verdict, score & filings →Is MAAS a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.